Skip to content
Use caution Drug recall · FDA · Published May 31, 2018

ICU Medical 0.9% Sodium Chloride Injection Recall: Potential Leaks

ICU Medical recalls 250mL 0.9% Sodium Chloride Injection bags due to potential leaks. This could compromise sterility and pose infection risks. Check your product details to see if affected.

🇺🇸 FDA recall #D-0882-2018DrugICU Medical ›
Take action

Contact the company

Recalling firmICU Medical Inc600 N FIELD DRIVE · LAKE FOREST, IL 60045
✎ GovInfoNow plain-language explainer

What happened, in plain English

ICU Medical is recalling 250mL 0.9% Sodium Chloride Injection bags because they may leak, which could lead to contamination. This affects medical use only and requires immediate attention to prevent infection risks. Read more at govinfonow.com/recall/40501-icu-medical-0-9-sodium-chloride-injection-recall-potential-leaks.

Source Summary by GovInfoNow · govinfonow.com/recall/40501-icu-medical-0-9-sodium-chloride-injection-recall-potential-leaks · Updated October 7, 2026 · FDA enforcement record: FDA #D-0882-2018

Cite this page

“ICU Medical 0.9% Sodium Chloride Injection Recall: Potential Leaks.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40501-icu-medical-0-9-sodium-chloride-injection-recall-potential-leaks. Based on FDA recall #D-0882-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0882-2018%22&limit=1).

Why it’s dangerous

The bags may leak, which could compromise sterility. This means the solution might become contaminated, increasing the risk of infection for patients during medical procedures.

Who’s affected

Healthcare professionals and hospitals using this specific injection product. Patients receiving treatment with this product are at risk if the bag leaks.

How to tell if you have this one

Check for the product name '0.9% Sodium Chloride Injection, USP, 250 mL bag, Rx Only' with manufacturer Hospira, Inc. and lot numbers 85-018-JT or 85-031-JT from the expiration date 01/01/2020.

  • Brand
    ICU Medical
  • Category
    Drug
FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide and Canada
Recall numberProduct, codes & lotsQuantity
D-0881-20180.45% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7730-37; Lot #: 85-023-JT, Exp 7/1/201988960 bags
D-0882-20180.9% Sodium Chloride Injection, USP, 250 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7983-02; Lot #: 85-018-JT, 85-031-JT, Exp. 01/01/2020941496 bags
D-0883-20180.9% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7984-23; Lot #: 85-016-JT, Exp 01/01/2020525984 bags
D-0884-20180.9% Sodium Chloride Injection, USP, 100 mL bag, Rx Only ,Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7984-37; Lot #: 85-021-JT, Exp 01/012020; 86-001-JT, Exp 02/01/20201247200 bags
D-0885-20185% Dextrose Injection, USP, 250 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7922-02; Lot #: 86-033-JT, Exp 08/01/2019267288 bags
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers 85-018-JT or 85-031-JT on the bag's label.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: May 31, 201812. FDA classified it Class II: Jun 20, 201823. Published in FDA’s Enforcement Report: Jun 27, 201834. FDA terminated the recall: Jun 4, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0882-2018 (May 31, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0882-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA